Effects of lithium and haloperidol on human sperm motility in‐vitro

Meng-Ru Shen, Rei‐Cheng ‐C Yang, Shun‐Sheng ‐S Chen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Abstract— Two psychotropic drugs, lithium and haloperidol, were evaluated for their in‐vitro effects on sperm motility using a transmembrane migration method. Sperm motility was measured either immediately after semen had been mixed with the drug or after a 2 h incubation period at 37°C. Lithium inhibited human sperm motility in a dose‐dependent manner with an EC50 of 10 Mm when the semen‐lithium mixture had been incubated. Sperm motility was increased to 127% of control when semen had been incubated with 0027 μm haloperidol; this concentration was within the therapeutic range. 1992 Royal Pharmaceutical Society of Great Britain

Original languageEnglish
Pages (from-to)534-536
Number of pages3
JournalJournal of Pharmacy and Pharmacology
Volume44
Issue number6
DOIs
Publication statusPublished - 1992 Jan 1

Fingerprint

Sperm Motility
Haloperidol
Lithium
Semen
Psychotropic Drugs
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Shen, Meng-Ru ; Yang, Rei‐Cheng ‐C ; Chen, Shun‐Sheng ‐S. / Effects of lithium and haloperidol on human sperm motility in‐vitro. In: Journal of Pharmacy and Pharmacology. 1992 ; Vol. 44, No. 6. pp. 534-536.
@article{d12734e86b174fe3953cad1da6a4b72b,
title = "Effects of lithium and haloperidol on human sperm motility in‐vitro",
abstract = "Abstract— Two psychotropic drugs, lithium and haloperidol, were evaluated for their in‐vitro effects on sperm motility using a transmembrane migration method. Sperm motility was measured either immediately after semen had been mixed with the drug or after a 2 h incubation period at 37°C. Lithium inhibited human sperm motility in a dose‐dependent manner with an EC50 of 10 Mm when the semen‐lithium mixture had been incubated. Sperm motility was increased to 127{\%} of control when semen had been incubated with 0027 μm haloperidol; this concentration was within the therapeutic range. 1992 Royal Pharmaceutical Society of Great Britain",
author = "Meng-Ru Shen and Yang, {Rei‐Cheng ‐C} and Chen, {Shun‐Sheng ‐S}",
year = "1992",
month = "1",
day = "1",
doi = "10.1111/j.2042-7158.1992.tb03664.x",
language = "English",
volume = "44",
pages = "534--536",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "6",

}

Effects of lithium and haloperidol on human sperm motility in‐vitro. / Shen, Meng-Ru; Yang, Rei‐Cheng ‐C; Chen, Shun‐Sheng ‐S.

In: Journal of Pharmacy and Pharmacology, Vol. 44, No. 6, 01.01.1992, p. 534-536.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of lithium and haloperidol on human sperm motility in‐vitro

AU - Shen, Meng-Ru

AU - Yang, Rei‐Cheng ‐C

AU - Chen, Shun‐Sheng ‐S

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Abstract— Two psychotropic drugs, lithium and haloperidol, were evaluated for their in‐vitro effects on sperm motility using a transmembrane migration method. Sperm motility was measured either immediately after semen had been mixed with the drug or after a 2 h incubation period at 37°C. Lithium inhibited human sperm motility in a dose‐dependent manner with an EC50 of 10 Mm when the semen‐lithium mixture had been incubated. Sperm motility was increased to 127% of control when semen had been incubated with 0027 μm haloperidol; this concentration was within the therapeutic range. 1992 Royal Pharmaceutical Society of Great Britain

AB - Abstract— Two psychotropic drugs, lithium and haloperidol, were evaluated for their in‐vitro effects on sperm motility using a transmembrane migration method. Sperm motility was measured either immediately after semen had been mixed with the drug or after a 2 h incubation period at 37°C. Lithium inhibited human sperm motility in a dose‐dependent manner with an EC50 of 10 Mm when the semen‐lithium mixture had been incubated. Sperm motility was increased to 127% of control when semen had been incubated with 0027 μm haloperidol; this concentration was within the therapeutic range. 1992 Royal Pharmaceutical Society of Great Britain

UR - http://www.scopus.com/inward/record.url?scp=0026764658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026764658&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.1992.tb03664.x

DO - 10.1111/j.2042-7158.1992.tb03664.x

M3 - Article

VL - 44

SP - 534

EP - 536

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 6

ER -